Treatment of Milia in Pediatric Patients
For typical primary milia in children, observation with reassurance is the recommended first-line approach, as these lesions are benign and often self-resolve; however, when treatment is desired for cosmetic reasons or for persistent/extensive variants, topical tretinoin is an effective first-line therapeutic option, with CO₂ laser vaporization reserved for refractory cases or extensive milia en plaque.
Clinical Context and Natural History
Milia are benign, superficial keratinous cysts presenting as small white papules, typically 1-2 mm in diameter. In pediatric patients, these lesions are generally self-limited and pose no health risk. The primary indication for treatment is cosmetic concern rather than medical necessity.
Treatment Algorithm
First-Line: Observation
- Most primary milia in children resolve spontaneously without intervention
- Reassurance to parents is often sufficient management
- No treatment-related risks or side effects
Second-Line: Topical Tretinoin
When treatment is pursued for cosmetic reasons or persistent lesions, topical tretinoin offers an effective, non-invasive option 1. A case report demonstrated successful treatment of milia en plaque of the nose in a 7-year-old boy using topical tretinoin, representing a novel treatment approach in the pediatric population 1.
Key advantages:
- Non-invasive application
- Minimal side effects in children
- Effective for both isolated milia and milia en plaque variants
- Can be applied at home by caregivers
Third-Line: CO₂ Laser Vaporization
For extensive, refractory, or cosmetically significant cases, CO₂ laser vaporization in superpulsed and focused mode at 2 W/cm² with two passes per session provides excellent cosmetic results with minimal side effects 2. A case series including pediatric patients (ages 12-50 years) with various milia variants showed marked improvement after few sessions with 12-36 month follow-up demonstrating no recurrence or notable adverse effects 2.
Indications for laser therapy:
- Multiple eruptive milia unresponsive to topical treatment
- Milia en plaque (rare variant with multiple lesions on erythematous plaques)
- Significant cosmetic concern warranting more aggressive intervention
- Failed topical therapy
Special Variants Requiring Recognition
Milia En Plaque
This rare variant presents as multiple milia-like lesions overlying erythematous, edematous plaques 3. While extremely uncommon in children (only 9 pediatric cases reported as of 2014), it requires more aggressive treatment than isolated milia. Both topical tretinoin 1 and CO₂ laser 2 have demonstrated efficacy.
Multiple Eruptive Milia
This presentation involves gradual onset of multilobulated cysts, typically on the face 4. Treatment approach follows the same algorithm, though these patients may benefit more from laser therapy given the extent of involvement.
Important Caveats
Do not confuse milia with more serious conditions. When evaluating any pediatric "lump or bump," maintain vigilance for atypical features suggesting aggressive processes 5. Red flags include:
- Rapid growth
- Ulceration or bleeding
- Size >5mm
- Irregular borders or color variation
- Associated systemic symptoms
Secondary milia in blistering diseases: When milia occur in the context of epidermolysis bullosa or other blistering disorders, they represent a secondary phenomenon related to disrupted sweat glands or hair follicles during healing 6. Treatment focuses on the underlying condition rather than the milia themselves.
Practical Implementation
For topical tretinoin therapy:
- Start with lower concentrations (0.025-0.05%) to minimize irritation
- Apply once daily at bedtime to affected areas
- Expect gradual improvement over weeks to months
- Counsel families about potential initial irritation
For CO₂ laser therapy:
- Requires dermatologist or trained specialist
- Typically requires multiple sessions
- Excellent long-term outcomes with minimal scarring risk in experienced hands
- Consider for patients age 12 and older when cooperation is optimal